Israel Englander Pyxis Oncology, Inc. Call Options Transaction History
Millennium Management LLC
- $199 Billion
- Q3 2024
Call Options
2 transactions
Others Institutions Holding PYXS
# of Institutions
100Shares Held
28.1MCall Options Held
539KPut Options Held
54.1K-
Deep Track Capital, LP Greenwich, CT4.18MShares$17.9 Million0.57% of portfolio
-
Laurion Capital Management LP New York, NY3.63MShares$15.5 Million0.18% of portfolio
-
Black Rock Inc. New York, NY2.79MShares$11.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.43MShares$10.4 Million0.0% of portfolio
-
Blue Owl Capital Holdings LP New York, NY1.13MShares$4.82 Million1.36% of portfolio
About Pyxis Oncology, Inc.
- Ticker PYXS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,096,400
- Market Cap $150M
- Description
- Pyxis Oncology, Inc., a preclinical stage biopharmaceutical company, engages in the development of therapies to treat cancers. Its immune-oncology product candidates include PYX-106, an investigational fully human immunoglobulin G1 isotype siglec-15 targeting antibody for the treatment of thyroid cancer, head and neck squamous cell carcinoma, no...